Katalog der Deutschen Nationalbibliothek

Expertensuche ?

Servicezeiten in Frankfurt am Main ab 1. Dezember 2025: Montag bis Freitag 9–18 Uhr und Samstag 10–16 Uhr
Service hours in Frankfurt am Main from 1 December 2025: Monday to Friday 9:00-18:00 and Saturday 10:00-16:00

Dienstag 9. Dezember 2025: Die Lesesäle der Deutschen Nationalbibliothek in Leipzig öffnen wegen einer Personalversammlung erst ab 13 Uhr. // Tuesday 9 December 2025: The reading rooms of the German National Library in Leipzig will open at 13:00 due to a staff assembly.

Ergebnis der Suche nach: "Originator"
im Bestand: Gesamter Bestand

41 - 50 von 129

	41	Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective study including switch from the originator and initiation of treatment Enthalten in Journal of neurology 9.2.2019: 1-6
	42	Bettymania and the Death of Celebrity Culture Enthalten in Historical social research / Supplement 2019, Nr. 32: 139-164
	43	É possível ver imagens? (ou do porquê van Fraassen deveria rever a sua abordagem em relação a elas) Gava, Alessio. - Mannheim, 2018
	44	Incorporating historical information in biosimilar trials: Challenges and a hybrid Bayesian‐frequentist approach Enthalten in Biometrical journal Bd. 60, 2018, Nr. 3: 564-582. 19 S.
	45	Conformity and Influence Enthalten in The B.E. journal of theoretical economics Bd. 19, 2018, Nr. 1. 29 S.
	46	Long-term effectiveness and safety of switching from originator to biosimilar infliximab in patients with Behçet’s disease Enthalten in Internal and emergency medicine 25.10.2018: 1-4
	47	Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study Enthalten in BioDrugs 20.10.2018: 1-11
	48	The Importance of Originator-Servicer Affiliation in Loan Renegotiation Enthalten in The journal of real estate finance and economics 31.7.2018: 1-34
	49	Comparative risk/benefit profile of biosimilar and originator erythropoiesis-stimulating agents (ESAs): data from an Italian observational study in nephrology Enthalten in European journal of clinical pharmacology 10.2.2018: 1-6
	50	Comparative efficacy and safety of biosimilar adalimumab and originator adalimumab in combination with methotrexate in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials Enthalten in Clinical rheumatology 1.2.2018: 1-7